Trials / Completed
CompletedNCT04920513
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (actual)
- Sponsor
- King Hussein Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aim to study the pattern and frequency of pathogenic variants among ALL newly diagnosed cancer patients in a genetically distinct population. Additionally, the investigators will study the uptake rate of "cascade family screening", frequency of pathogenic variants and barriers against testing.
Conditions
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2021-06-10
- Last updated
- 2025-03-19
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT04920513. Inclusion in this directory is not an endorsement.